Asklepios BioPharmaceutical, Inc. (AskBio)

Asklepios BioPharmaceutical, Inc. (AskBio)

Biotechnology Research

Research Triangle Park, North Carolina 35,432 followers

Pioneering science to create transformative molecular medicines.

About us

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: • Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. • Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. • Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. • Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. • Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.

Website
http://www.askbio.com
Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
Research Triangle Park, North Carolina
Type
Privately Held
Founded
2001
Specialties
AAV, Adeno-Associated Virus, Gene Therapy, Rare Disease, AAV Manufacturing, Molecular Medicine, Nucleic Acid, Epigenome, and Doggybone DNA

Locations

Employees at Asklepios BioPharmaceutical, Inc. (AskBio)

Updates

  • A successful internship program combines on-the-job training and time for building strong bonds with colleagues. Yesterday, on #NationalInternsDay, Sofia Mejia, a member of our 2024 class, and KaCie Willis (Lynk), from our Talent Acquisition Team, hosted a pop culture team-building trivia event for this year’s interns. This was a fun way to “Cultivate Collaboration,” which is a core #AskBio value, and bring the group closer together as they continue to learn about #genetherapy and emerging therapeutics for patients in need. #teamwork #values 

    • No alternative text description for this image
  • #AskBio employees are on a mission to lead innovative science. For Holly Schroeder, PhD from our Gene Editing team, this translates into the opportunity to make a significant contribution and impact on the relatively “young” field of #genetherapy and gene editing. Watch to learn more from Holly and visit https://lnkd.in/ejPBtp8 to explore opportunities in gene therapy. Let’s make history together.

  • We recently announced our new Volunteer Time Off (VTO) program, providing two days each year for employees to volunteer and make a difference. Our Finance Team proudly kicked off the program with an event at Rise Against Hunger. Over 50 employees gathered at the Raleigh, NC warehouse to package 10,000 meals, fostering team spirit and significantly impacting global hunger relief. OUR IMPACT: 10,000 meals were sent to Madagascar, an island nation off the southeastern coast of Africa, which is home to over 28 million people. The nation faces high rates of poverty, food insecurity, and chronic malnutrition. Jenny Siferd, SPHR, Talent Attraction, emphasized, “Volunteering for a good cause boosts mental health, teaches valuable skills, provides a greater sense of purpose, and brings more fulfillment into our lives.” Anand Thaker from Accounting and Tax reflected, “Volunteering with our cross-functional colleagues truly highlighted the power of collective effort. When we act as ONE team, we deliver exceptional results, build meaningful relationships, and make a tangible difference in the community.” We’re excited to see how others will use their VTO to keep this momentum going. Maryam Faridounnia Nadja Hunter, MBA Delicia Bryant #AskBio #RiseAgainstHunger #CommunityEngagement

  • We’re excited to share that AB-1005, which is being developed for moderate Parkinson’s disease, received US FDA Fast Track and UK MHRA Innovation Passport designations. There's a huge unmet need for #Parkinson's treatment, and these designations take us another step closer to accelerating access for patients. We at #AskBio, alongside Bayer | Pharmaceuticals, are dedicated to providing patients with innovative therapies and, most importantly, improving patient outcomes. #genetherapy   For Medical Media – Read our press release here: https://lnkd.in/g7Mr854f  

    • No alternative text description for this image
  • As our friends and colleagues in the US pause to celebrate Independence Day, we’re reminded that the summer holiday season in North America and Europe provides the perfect opportunity for many of our employees to take a well-deserved break. In line with that, we instituted our “Summer Days” program, which provides #AskBio teams around the world with three additional days off that can be used between June and August. Happy 4th to everyone in the US and all the best to everybody this summer. #WorkLifeBalance  

  • We’re excited to share that our Chief Scientific Officer, Mansuo L Shannon, has been elected to the #AskBio Board of Directors. She brings an important perspective and expertise to the Board and will be a key voice as we continue to develop our preclinical pipeline and platform technologies. We look forward to all that Mansuo will do to ensure that AskBio continues to innovate and remain at the leading edge of science. Congratulations, Mansuo! #Leadership #GeneTherapy

  • At #AskBio we believe strength lies in our diversity and our Employee Resource Groups help bring this to life through ongoing educational events and campus activities. A big thank you to our LGBTQ Employee Resource Group for planning and hosting a series of inspiring events to celebrate Pride Month. Pride Month is a time to honor the courage, resilience, and achievements of the LGBTQ community. It is a celebration of diversity, love, and the ongoing fight for equality. Let’s carry forward the spirit of Pride Month and continue to raise the bar, pioneer new paths, and celebrate the vibrant tapestry of our community. Together, we are stronger, more creative, and capable of achieving extraordinary things.

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • “Our goal is to harness the power of gene therapy to improve patient lives globally,” Jude Samulski, co-founder and current board member of AskBio states while sharing his insights on the future of #genetherapy in a recently published article in Nature. This article shines a light on AskBio’s pioneering spirit and unwavering commitment to forging a new path where gene therapy can transform countless lives. At #AskBio, we are on the forefront of innovation, dedicated to advancing research and embracing cutting-edge science to revolutionize the field of gene therapy and make strides for a brighter future for all. Read the article (accessible with a subscription) and let us know what you think. https://lnkd.in/efQHZcmj

    Gene therapies start the climb from rare disease base camps to common disease peaks

    Gene therapies start the climb from rare disease base camps to common disease peaks

    nature.com

  • At #AskBio we believe strength lies in our diversity and our Employee Resource Groups (ERGs) help bring this to life through ongoing educational events and campus activities. On the eve of Juneteenth, we gathered for an informative and engaging trivia session that not only tested our knowledge but also deepened our understanding of this pivotal moment in American history. Through fun and friendly competition, we explored the origins of Juneteenth, key historical figures, and significant milestones in the journey toward freedom and equality for all. The following day, we took time off to reflect on the significance of Juneteenth. This pause allowed us to contemplate the meaning of freedom and the ongoing struggle for equality. It's a reminder of the progress we've made and the work that still lies ahead. As we carry these lessons forward, on Thursday, June 27th our African American ERG will launch our third Summer Immersion Program. The program introduces junior and senior high school students from across North Carolina to a laboratory environment and also introduces them to careers in the biopharmaceutical industry. Together, we can reimagine what is possible. #leadership #genetherapy

    • No alternative text description for this image
    • No alternative text description for this image
  • Today we announced the initiation of recruitment to REGENERATE-PD, a Phase 2 clinical study assessing the efficacy and safety of AB-1005, an investigational #genetherapy for the treatment of moderate-stage Parkinson’s disease. More than 10 million people worldwide suffer from Parkinson’s disease, with approximately 1 million living in the United States. #AskBio is dedicated to advancing research and embracing cutting-edge science to explore gene therapy solutions for this debilitating disease. For Medical Media – Read our press release here: https://lnkd.in/g478gFVH #ParkinsonsDisease

    • No alternative text description for this image

Similar pages

Browse jobs

Funding